• Skip to main content
  • Skip to footer
Log Out

Oncology Resource Group

Oncology Competitive Intelligence Leaders

  • ONCrg Full Support™
    • ONCrg Conference™
    • ONCrg Pipeline Strategies™
    • ONCrg Sentinel™
    • ONCrg Advisory™
  • Oncology Coverage
        • SOLID TUMORS
          • Bladder
          • Breast
          • Colorectal
          • Endometrial
          • Esophageal
          • Gastric
          • Gliomas
          • HCC
          • HNSCC
          • Melanoma
          • NSCLC
          • Ovarian
          • Pancreatic
          • Prostate
          • RCC
          • SCLC
          • STS
        • IMMUNO-ONCOLOGY
          • Emerging IO
          • Late Stage IO
        • MOAs
          • ADC
          • Cell Therapies
          • DDR
        • HEMATOLOGIC MALIGNANCIES
          • ALL
          • AML
          • CLL
          • MDS
          • MM
          • MPNs
          • NHL
        • CONFERENCES
          • ASCO GI
          • ASCO GU
          • SGO
          • ELCC
          • AACR
          • ASCO
          • EHA
          • WCLC
          • ESMO
          • SITC
          • SNO
          • ASH
          • SABCS
  • About ONCrg
    • About ONCrg
    • Our Team
    • Careers
    • Contact
    • Home
  • Contact
  • Login
Sarah Lockhead, Ph.D.

Sarah received her Ph.D. in Chemical and Systems Biology at Stanford. Her unique background encompasses multiple areas of drug development, from preclinical oncology research at Pfizer to drug repurposing at Stanford’s School of Medicine. Her breadth of experience enables her to provide her clients with incisive drug landscape analyses and key insights.

Footer


ONCrg is a Division of





ONCrg Full Support™
ONCrg Conference™
ONCrg Pipeline Strategies™
ONCrg Sentinel™
ONCrg Advisory™

About ONCrg
About ONCrg
Our Team
Careers
Contact
Home Page

Solid Tumors
Bladder
Breast
Colorectal
Endometrial
Esophageal
Gastric
Gliomas
HCC
HNSCC
Melanoma
NSCLC
Ovarian
Pancreatic
Prostate
RCC
SCLC
STS

Hematologic
Malignancies

ALL
AML
CLL
MDS
MM
MPNs
NHL

Immuno-Onc
Emerging IO
Late Stage IO

MOA Reports
ADC
Cell Therapies
DDR

Conferences
ASCO GI
ASCO GU
SGO
ELCC
AACR
ASCO
EHA
WCLC
ESMO
SITC
SNO
SABCS
ASH

ONCrg Full Support™
ONCrg Conference™
ONCrg Pipeline Strategies™
ONCrg Sentinel™
ONCrg Advisory™

About ONCrg
About ONCrg
Our Team
Careers
Contact
Home Page

Solid Tumors
Bladder
Breast
Colorectal
Endometrial
Esophageal
Gastric
Gliomas
HCC
HNSCC
Melanoma
NSCLC
Ovarian
Pancreatic
Prostate
RCC
SCLC
STS

Hematologic
Malignancies

ALL
AML
CLL
MDS
MM
MPNs
NHL

Immuno-Onc
Emerging IO
Late Stage IO

MOA Reports
ADC
Cell Therapies
DDR

Conferences
ASCO GI
ASCO GU
SGO
ELCC
AACR
ASCO
EHA
WCLC
ESMO
SITC
SNO
SABCS
ASH


ONCrg is a Division of


BioPharma Resource Groups
Michael Reynolds +1 650.485.2626
CardioVascular Resource Group
Brooke Blackwelder +1 541.977.1516
Oncology Resource Group
Brooke Blackwelder +1 541.977.1516

 

 

© Copyright 2004-2022 · BioPharma Resource Groups      |      Privacy Policy